CARDIUM THRPTCS

Inactive Instrument

Insiders CARDIUM THRPTCS Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

2022	Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt	CI
2021	Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	CI

Insiders

Gene Biotherapeutics, Inc. Announces Resignation of Murray H. Hutchison from the Board	21-07-28	CI
Gene Biotherapeutics, Inc. Announces Management Changes	20-05-28	CI
Gene Biotherapeutics Inc. Announces Retirement of Gerald J. Lewis from its Board of Directors	19-03-20	CI
Taxus Cardium Pharmaceuticals Group, Inc. Announces Board Retirements	16-12-14	CI
Dennis Mulroy Resigns as Chief Financial Officer of Taxus Cardium Pharmaceuticals Group Inc on April 3, 2015	15-04-03	CI
TaxuCardium Pharmaceuticals Group Inc. Announces Election of New Directors	15-01-15	CI
Cardium Therapeutics, Inc. has Changed its Name to Taxus Cardium Pharmaceuticals Group Inc	14-03-17	CI
Cardium Therapeutics Inc. Announces Medical Advisory Board to Support Excellagen Advanced Wound Care Product	12-09-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters